Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

AccesswireJan 15 08:00 ET

Sunshine Biopharma Files For Offering Of Mixed Shelf Of Up To $100M

BenzingaJan 6 11:56 ET

Express News | Sunshine Biopharma Announces Development Of An Orally Active Protease Inhibitor With Dose-Dependent Antiviral Activity In Mice With SARS-CoV-2)

BenzingaDec 9, 2024 07:36 ET

Express News | Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $15 Price Target

BenzingaDec 5, 2024 11:37 ET

Sunshine Biopharma Analyst Ratings

BenzingaDec 5, 2024 11:35 ET · Ratings

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 MRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

AccesswireDec 2, 2024 08:00 ET